Thus, impairing this route of selenocysteinyl-tRNA formation in conjunction with xCT inhibition could have even more potent effects, and the potential functions of SCLY in cancer and ferroptosis should be explored in future studies. This evidence concerns the gene SLC7A11 and cancer.